|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 974.85 Million
|
|
Market Size (2030)
|
USD 1478.02 Million
|
|
CAGR (2025-2030)
|
7.14%
|
|
Fastest Growing Segment
|
Consumables
|
|
Largest Market
|
Kanto
|
Market Overview
Japan Infection Control Supplies Market was valued at
USD 974.85 Million in 2024 and is expected to reach USD 1478.02
Million by 2030 with a CAGR of 7.14% during the forecast period. The Japan
Infection Control Supplies Market is driven by several key factors. The growing
emphasis on infection prevention in healthcare settings due to the rising
incidence of healthcare-associated infections is crucial. The COVID-19 pandemic
has further accelerated the demand for infection control supplies such as
personal protective equipment (PPE), disinfectants, and sterilization products.
Government regulations and standards enforcing stringent infection control
measures in hospitals and clinics also contribute to market growth. Increasing
awareness among the public and healthcare professionals about the importance of
hygiene and infection prevention fuels demand. Technological advancements in
infection control products, including more effective and user-friendly
solutions, enhance market growth. The continuous focus on improving healthcare
infrastructure and readiness for future pandemics also drives investment in
infection control supplies.
Key Market Drivers
Rising Incidence of Healthcare-Associated
Infections (HAIs)
The incidence of healthcare-associated infections
(HAIs) in Japan is a major driver of the Japan Infection Control Supplies
Market. HAIs, including infections acquired during hospital stays or healthcare
procedures, represent a significant concern within the healthcare system due to
their impact on patient outcomes and healthcare costs. In Japan, the prevalence
of HAIs has prompted increased vigilance and investment in infection control
practices across healthcare settings. Healthcare-associated infections
encompass a range of conditions such as surgical site infections,
catheter-associated urinary tract infections, central line-associated
bloodstream infections, and ventilator-associated pneumonia. These infections
not only complicate patient care but also contribute to prolonged hospital
stays, increased healthcare costs, and, in severe cases, patient mortality. To
combat these issues, healthcare facilities in Japan are prioritizing the
implementation of comprehensive infection control measures.
In response to the growing incidence of HAIs, there
has been a notable surge in demand for various infection control supplies.
Hospitals and clinics are investing in advanced disinfectants, sterilization
equipment, and personal protective equipment (PPE) to enhance their infection
control protocols. For example, surface disinfectants and high-level
disinfectants are crucial for decontaminating hospital environments, while
sterilization products are essential for ensuring that medical instruments are
free from pathogenic microorganisms. The increased focus on preventing HAIs is
supported by national and regional healthcare guidelines that mandate stringent
infection control practices. These guidelines often require healthcare
facilities to adopt evidence-based protocols and utilize specific infection
control products to minimize the risk of infections. As a result, there is a
growing market for infection control supplies that meet these regulatory
standards and address the challenges posed by HAIs.
The rise in HAIs has led to greater awareness among
healthcare professionals and the public about the importance of infection
prevention. This awareness drives demand for infection control products and
services, as stakeholders seek solutions to reduce infection rates and improve
patient safety. The continuous evolution of infection control strategies and
the development of new technologies further contribute to market growth, as
healthcare facilities seek innovative solutions to address emerging infection
threats.
Technological Advancements
Technological advancements are a significant driver
of the Japan Infection Control Supplies Market, as innovations in product
design, materials, and technologies enhance the effectiveness of infection
control measures. Advances in infection control technology contribute to better
prevention and management of infections, driving market growth and creating opportunities
for suppliers and manufacturers. One notable area of technological advancement
is the development of high-performance disinfectants and sterilization
equipment. Modern disinfectants are formulated with advanced antimicrobial
agents that offer improved efficacy against a broad spectrum of pathogens.
Similarly, sterilization technologies have evolved to include more efficient
and automated systems, such as vaporized hydrogen peroxide sterilizers and UV-C
light disinfection systems. These technologies enhance the ability to maintain
sterile environments and reduce the risk of infection transmission. In July
2020, Omron Asia Pacific announced a partnership with Techmetics Robotics LLC
to introduce the OMRON LD-UVC mobile robot. This new disinfection robot
incorporates advanced features designed to enhance pathogen elimination,
safety, and autonomy. Omron highlighted that UVC light effectively disrupts
pathogens' DNA and RNA, rendering them unable to replicate. The OMRON LD-UVC
robot is capable of autonomous navigation and can disinfect various areas,
including high-touch surfaces, by delivering precise doses of UVC energy. The
company claims that the robot can eliminate up to 99.90% of both airborne and
droplet bacteria and viruses.
The design and materials used in personal
protective equipment (PPE) have also seen significant improvements. New
materials with enhanced barrier properties and comfort features contribute to
better protection and usability for healthcare workers. Innovations in PPE
include the development of multi-layered masks with higher filtration
efficiency, as well as ergonomic designs that improve fit and comfort during
extended use. Advancements in infection control technology extend beyond
traditional products to include smart and connected solutions. For example,
IoT-enabled disinfection systems allow for real-time monitoring and management
of infection control measures. These smart technologies provide valuable data
and insights to optimize infection prevention strategies and ensure compliance
with hygiene protocols. The continuous evolution of infection control
technologies drives market growth by addressing emerging infection threats and
meeting the demands of modern healthcare environments. As new technologies are
developed and introduced, healthcare facilities seek to adopt the latest
solutions to improve infection control practices and enhance patient safety.
The ongoing investment in research and development by manufacturers and
suppliers contributes to the expansion of the Japan Infection Control Supplies
Market and the availability of innovative products.
Aging Population and Chronic Disease Management
Japan's aging population and the rising prevalence
of chronic diseases are significant drivers of the Japan Infection Control Supplies
Market. As Japan experiences one of the world’s most rapidly aging populations,
there is an increasing demand for medical care and long-term health management,
which in turn drives the need for effective infection control measures. Elderly
individuals are more susceptible to infections due to age-related declines in
immune function, multiple comorbidities, and increased frequency of medical
treatments. This vulnerability necessitates stringent infection control
practices in both healthcare settings and long-term care facilities. For
instance, elderly patients often require hospitalization or residential care,
where the risk of infections such as healthcare-associated infections (HAIs)
and opportunistic infections is higher. Consequently, healthcare providers are
compelled to implement robust infection control protocols to safeguard these
patients. Chronic diseases, including diabetes, cardiovascular conditions, and
respiratory disorders, further exacerbate infection risks. Individuals with
chronic conditions are more prone to infections and often need ongoing medical
care, which increases their exposure to healthcare settings where infection
control is crucial. Managing chronic diseases requires consistent use of
infection control products such as antiseptics, wound care supplies, and
specialized cleaning agents to prevent complications and ensure effective
treatment.
The growing need for infection control measures in
long-term care facilities, including nursing homes and assisted living centers,
reflects the broader trend of addressing the health needs of the elderly
population. As these facilities expand and upgrade their services to
accommodate more residents, they invest in infection control supplies to
maintain hygiene standards and prevent outbreaks of infections. The Japanese
government and healthcare organizations are actively focusing on improving the
quality of care for the elderly, which includes enhancing infection control
practices. This focus translates into increased demand for infection control
products and services designed to meet the specific needs of the aging
population. The continued growth of Japan’s elderly population and the
management of chronic diseases are key factors driving sustained market growth
for infection control supplies.
Growth in the Health and Wellness Sector
The growth of the health and wellness sector is an
emerging driver of the Japan Infection Control Supplies Market. As awareness of
health and wellness continues to rise, there is a corresponding increase in demand
for products and practices that contribute to overall well-being, including
infection control measures. In recent years, there has been a significant shift
towards preventative health and proactive management of personal and
environmental hygiene. This trend is reflected in the growing popularity of
health and wellness products, including those focused on infection prevention.
Consumers are increasingly seeking products that offer enhanced protection
against infections and support a healthy lifestyle, driving demand for items
such as high-quality hand sanitizers, antimicrobial cleaning products, and air
purifiers.
The health and wellness sector encompasses a wide
range of products and services aimed at improving quality of life and
maintaining health. This includes not only personal hygiene products but also
environmental sanitation solutions designed to reduce the risk of infections in
various settings. For example, fitness centers, spas, and wellness retreats are
investing in advanced infection control measures to ensure a clean and safe
environment for their clients. The integration of infection control practices
into health and wellness routines reflects a growing understanding of the role
that hygiene plays in overall health. As more individuals and organizations
adopt infection control measures as part of their health and wellness
strategies, the market for infection control supplies expands, driven by the
demand for products that support a healthy and hygienic lifestyle.
Download Free Sample Report
Key Market Challenges
High Costs of Advanced Infection Control Products
The high costs associated with advanced infection
control products present a significant challenge in the Japan Infection Control
Supplies Market. Innovative infection control solutions, such as advanced
disinfectants, high-efficiency sterilization equipment, and sophisticated
personal protective equipment (PPE), often come with substantial price tags.
These costs can pose barriers to widespread adoption, particularly for smaller
healthcare facilities and organizations with limited budgets. Advanced infection
control products are typically developed with cutting-edge technologies and
materials, which contribute to their higher costs. For instance,
high-efficiency sterilizers and automated disinfection systems involve complex
engineering and specialized components, driving up their price. Similarly, PPE
designed with advanced materials and enhanced protective features can be
significantly more expensive than standard alternatives.
The high costs of these products can impact
healthcare facilities' ability to invest in and maintain comprehensive
infection control measures. Budget constraints may force facilities to
prioritize essential items over advanced solutions, potentially compromising
the effectiveness of their infection control practices. This is particularly
challenging for public health institutions and smaller clinics that operate
under tight financial constraints.
The cost of infection control supplies can also
affect the pricing and availability of products in the market. Higher costs may
lead to increased prices for end-users, potentially limiting access to
essential infection control measures for healthcare providers and consumers.
This can create disparities in the quality of infection control practices
across different regions and types of facilities. Addressing the challenge of
high costs requires a multi-faceted approach, including efforts to reduce
manufacturing costs, explore cost-effective alternatives, and advocate for
policies that support affordability and accessibility. Collaboration between
manufacturers, healthcare providers, and policymakers can help ensure that
advanced infection control solutions are available and accessible to those who
need them.
Supply Chain Disruptions
Supply chain disruptions are a significant
challenge for the Japan Infection Control Supplies Market, impacting the
availability and timely delivery of essential products. The COVID-19 pandemic
has highlighted vulnerabilities in global supply chains, affecting the
production and distribution of infection control supplies. These disruptions
have resulted in shortages, delays, and increased costs for products crucial to
infection prevention and control. Several factors contribute to supply chain
disruptions in the Japan Infection Control Supplies Market. For one, the global
demand for infection control products surged during the pandemic, leading to
supply shortages and increased competition for raw materials. Manufacturers
faced challenges in sourcing essential components and materials, impacting
their ability to produce and deliver products on time.
Logistical challenges, including transportation
delays and border restrictions, also played a role in supply chain disruptions.
International shipping and distribution networks were strained by increased
demand and pandemic-related restrictions, leading to delays in the delivery of
products to Japan. This was particularly problematic for time-sensitive
products such as PPE and disinfectants, which are critical for managing
infection outbreaks.
Disruptions in the supply chain can result in
increased costs for manufacturers and consumers. Rising prices for raw
materials and shipping can lead to higher product costs, which may be passed on
to end-users. This can create financial pressures for healthcare facilities and
organizations, especially those operating under budget constraints. To mitigate
the impact of supply chain disruptions, companies in the Japan Infection
Control Supplies Market must adopt strategies to enhance supply chain
resilience. This includes diversifying supply sources, investing in inventory
management, and establishing contingency plans for unforeseen disruptions.
Collaboration with suppliers, logistics partners, and government authorities
can also help address supply chain challenges and ensure the availability of
essential infection control products.
Key Market Trends
Increased Focus on Infection Control in
Non-Healthcare Settings
Beyond traditional healthcare environments, there
is a growing recognition of the need for effective infection control measures
in various public and private settings, including educational institutions,
offices, public transportation, and commercial establishments. The COVID-19
pandemic has heightened awareness of infection control practices in
non-healthcare environments, leading to a surge in demand for products such as
disinfectants, air purifiers, and hygiene solutions. Schools and educational
institutions, for example, have implemented enhanced cleaning protocols and
invested in infection control supplies to ensure the safety of students and
staff. Similarly, businesses and offices have adopted stricter hygiene
measures, including regular disinfection of high-touch surfaces and the
provision of hand sanitizers, to protect employees and customers.
Public transportation systems, including trains and
buses, have also seen increased investment in infection control measures. To
maintain passenger safety and prevent the spread of infections, transportation
authorities have introduced routine cleaning and disinfection procedures, as
well as upgraded air filtration systems. Commercial establishments, including
restaurants, hotels, and retail stores, have similarly adopted infection
control practices to reassure customers and ensure a safe environment. The
emphasis on infection control in these diverse settings reflects a broader
shift towards maintaining hygiene and preventing the spread of infections in
everyday life. This trend drives the demand for infection control products that
are suitable for a variety of environments, including those that require
frequent and effective sanitation solutions. As organizations across different
sectors continue to prioritize infection control, the market for these supplies
is expected to grow, with opportunities for innovation and expansion in both
product offerings and applications.
Rising Investment in Research and Development
The rising investment in research and development
(R&D) within the infection control industry is a significant driver of the Japan
Infection Control Supplies Market. Continuous innovation and advancements in
infection control technologies and products are crucial for addressing evolving
infection threats and improving the effectiveness of infection prevention
measures. Investment in R&D enables the development of new and improved
infection control products, including advanced disinfectants, sterilization
technologies, and PPE. For example, research into novel antimicrobial agents
and materials has led to the creation of more effective and longer-lasting
disinfectants. Similarly, advancements in sterilization technology, such as
low-temperature plasma sterilizers and automated disinfection systems,
contribute to enhanced infection control practices. Pharmaceutical companies,
biotechnology firms, and medical device manufacturers are actively investing in
R&D to develop innovative solutions that meet the needs of healthcare
providers and consumers. This investment is driven by the need to address
emerging infection threats, such as new pathogens and resistant strains of microorganisms.
The development of new technologies and products also helps to address existing
limitations and improve the overall efficacy of infection control measures. In January 2021 H. IKEUCHI & CO.,
LTD., a prominent Japanese manufacturer of industrial and commercial spray
nozzles, officially launched the full-scale sales of its new backpack
disinfection device, named "Dry-Fog HIGHNOW." The Dry-Fog HIGHNOW
(DFH) is a backpack-style disinfection device that utilizes a patented nozzle
from IKEUCHI to dispense a disinfectant solution as "Dry Fog," with
droplets measuring 10 micrometers or less.
Government and private sector funding for infection
control research further supports market growth by fostering innovation and
accelerating the introduction of new products. Collaboration between research
institutions, industry players, and regulatory agencies ensures that R&D
efforts are aligned with current infection control needs and standards. The
ongoing focus on R&D in the infection control sector drives market expansion
by providing healthcare facilities and consumers with advanced solutions that
enhance infection prevention and control. As research continues to yield new
discoveries and technologies, the market for infection control supplies is
expected to grow, driven by the demand for innovative and effective products.
Segmental Insights
Type Insights
Based on the type, Consumables
currently dominate as the leading segment in the Japan Infection Control
Supplies Market, a position underscored by their fundamental role in
maintaining effective infection control across a variety of settings, from
healthcare facilities to public spaces. This prominence arises from the
indispensable nature of consumable items, which are integral to preventing the
spread of infections and ensuring rigorous hygiene standards. The consumables
segment includes a diverse array of products, each contributing uniquely to
infection control and public health. Personal protective equipment (PPE)
represents a cornerstone of the consumables market. PPE includes essential
items such as gloves, masks, gowns, and face shields. The COVID-19 pandemic has
dramatically highlighted the critical importance of PPE. Healthcare workers,
who are at the forefront of managing infectious diseases, rely heavily on these
protective items to shield themselves and their patients from pathogens. The
heightened global focus on infection prevention during the pandemic led to a
surge in the production and consumption of PPE, a trend that continues as
organizations and individuals maintain heightened awareness of hygiene. The
demand for PPE is sustained not only by healthcare facilities but also by a
range of public and private sectors, including education, retail, and
transportation, where protection against infectious agents is crucial.
Disinfectants and
antiseptics form another vital component of the consumables segment. These
products are essential for the effective cleaning and sanitizing of surfaces
and hands, playing a crucial role in preventing cross-contamination and
reducing the risk of infection. Disinfectants are widely used in healthcare
environments, such as hospitals and clinics, where maintaining sterile
conditions is imperative. Their use extends to public spaces and commercial
settings where regular cleaning is necessary to ensure a hygienic environment.
The rise in awareness about the role of hygiene in preventing disease
transmission has led to sustained demand for effective disinfectants and
antiseptics, which are available in various formulations to meet different
needs.
End User Insights
Based on end user, hospitals
are the dominant segment. This dominance is primarily due to the critical and
continuous need for infection control measures within healthcare settings,
where the risks of infection are highest and the stakes are most significant.
Hospitals require a comprehensive array of infection control supplies to ensure
the safety of patients, staff, and visitors, driving a substantial and
consistent demand for these products. Hospitals, as major healthcare providers,
are at the forefront of implementing stringent infection control protocols.
They are essential environments where the risk of healthcare-associated
infections (HAIs) is considerable due to the presence of immunocompromised
patients and invasive procedures. This necessitates the regular use of a wide
variety of infection control supplies, including personal protective equipment
(PPE), disinfectants, antiseptics, hand sanitizers, and cleaning agents.
Personal protective equipment
(PPE) is particularly critical in hospital settings. Items such as gloves,
masks, gowns, and face shields are essential for protecting healthcare workers
from exposure to infectious agents. The importance of PPE in preventing the
spread of infections within hospitals cannot be overstated, and the high demand
for these products within hospital settings drives a significant portion of the
Japan Infection Control Supplies Market. The COVID-19 pandemic has further
emphasized the necessity of PPE, leading to increased procurement and usage
across hospitals. Disinfectants and antiseptics also play a crucial role in
hospitals. Hospitals require potent disinfectants for cleaning and sanitizing
surfaces, medical equipment, and hands to prevent cross-contamination and the
spread of infections. The rigorous cleaning protocols in hospitals ensure that
all surfaces and equipment are free of pathogens, which is critical for
maintaining a sterile environment. This necessity drives continual procurement
of disinfectants and antiseptics, contributing to their dominance in the
infection control Japan Infection Control Supplies Market.
Download Free Sample Report
Regional Insights
Kanto stands out as the dominant region in the Japan
Infection Control Supplies Market. The Kanto region, which includes the capital
city of Tokyo and other major urban centers such as Yokohama, Chiba, and
Saitama, exerts a significant influence on the market due to its large
population, high density of healthcare facilities, and substantial economic
activity. The dominance of Kanto in the Japan Infection Control Supplies Market
is primarily driven by the concentration of healthcare institutions in this
region. Tokyo, as Japan's capital, is home to numerous major hospitals, medical
research institutions, and healthcare facilities that require a vast array of
infection control supplies. The high number of medical facilities in Tokyo and
its surrounding prefectures generates substantial demand for products such as
personal protective equipment (PPE), disinfectants, antiseptics, hand
sanitizers, and cleaning agents. The need for robust infection control measures
is amplified in this densely populated region, where the risk of disease
transmission is heightened due to the high volume of people and frequent
interactions.
Kanto's economic significance further contributes
to its dominance in the Japan Infection Control Supplies Market. As the
economic hub of Japan, the region has a high concentration of corporate
offices, educational institutions, and public spaces that also require
infection control products to maintain hygiene and prevent the spread of
infections. The economic activity in Kanto translates into a high demand for
infection control supplies across various sectors, including healthcare,
education, and business. The region's infrastructure also supports its leading
position in the market. Kanto boasts a well-developed transportation network,
including major airports, railways, and highways, which facilitates the
efficient distribution and logistics of infection control supplies. The
accessibility of transportation networks ensures that products can be delivered
promptly to healthcare facilities, businesses, and other institutions,
maintaining a steady supply of essential items.
Recent Developments
- In March 2024, AW
Technologies and Asahi Kasei Medical, a key entity of the Asahi Kasei Group,
have established an exclusive distribution agreement for the TrachFlush™ device
in Japan. AW Technologies is in the process of registering the TrachFlush as a
medical device in Japan, with plans to launch the product in fiscal year 2024. The
TrachFlush, developed by AW Technologies and based on an innovation by an
intensivist, is designed to alleviate discomfort for ventilated patients and
ease the burden on healthcare professionals during tracheal suctioning. This
device aids in managing airway secretions (phlegm) through a distinctive cuff
pressure control system. It has already received the CE Mark in Europe in 2020
and FDA clearance in the United States in 2023. In Japan, the marketing and
sales of the TrachFlush will be handled by Asahi Kasei Medical.
- In June 2023, Japanese
electronics leader Panasonic introduced its innovative smart wardrobe, the
HCC-R600A, featuring a range of advanced functionalities. This cutting-edge
wardrobe can silently disinfect, deodorize, and iron clothes while operating
quietly, ensuring it does not disturb anyone who is sleeping. The smart
wardrobe comes in two sub-models, designated left (L) and right (R), based on
the direction in which the door opens. Tested by the Japanese Food Research
Center, the Panasonic smart wardrobe is capable of reducing bacteria on
clothing by up to 99%, achieving this level of disinfection after just two
hours of operation.
- In June 2023, Japanese
analytical instrumentation firm Shimadzu Corporation partnered with US-based AI
and robotics specialist Shyld to advance a cutting-edge AI-powered ultraviolet
C (UV-C) disinfection technology. This innovative technology integrates
Shimadzu’s expertise in optics with Shyld’s advancements in AI, aiming to
transform the infection control sector. At Stanford Medical Center in
California, the Shyld AI disinfection technology has been installed in patient
rooms to automatically detect potential risks in real time and deploy UV-C
light to eradicate pathogens from various surfaces.
Key Market Players
- 3M Japan Limited
- Getinge Group Japan Co., Ltd.
- ASP Japan LLC
- Steris Japan Co., Ltd.
- Taiko Pharmaceutical Co., Ltd.
- Airtech Japan, Ltd.
- Japan Vilene Company, Ltd.
|
By Type
|
By End User
|
By Region
|
- Equipment
- Services
- Consumables
|
- Hospitals
- Medical Device Companies
- Clinical Laboratories
- Pharmaceutical Companies
- Others
|
- Hokkaido
- Tohoku
- Kanto
- Chubu
- Kansai
- Chugoku
- Shikoku
- Kyushu
|
Report Scope:
In this report, the Japan Infection Control
Supplies Market has been segmented into the following categories, in addition
to the industry trends which have also been detailed below:
- Japan Infection Control
Supplies Market, By
Type:
o Equipment
o Services
o Consumables
- Japan Infection Control
Supplies Market, By
End User:
o Hospitals
o Medical Device Companies
o Clinical Laboratories
o Pharmaceutical Companies
o Others
- Japan Infection Control
Supplies Market, By
Region:
o Hokkaido
o Tohoku
o Kanto
o Chubu
o Kansai
o Chugoku
o Shikoku
o Kyushu
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the Japan Infection Control Supplies Market.
Available Customizations:
Japan Infection Control Supplies Market report
with the given market data, TechSci Research offers customizations according to
a company's specific needs. The following customization options are available
for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Japan Infection Control Supplies Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]